SERINC3 Antikörper (AA 51-150) (FITC)

Produktnummer ABIN760158

Produktdetails anti-SERINC3 Antikörper (FITC)

Target: SERINC3 (Serine Incorporator 3 (SERINC3))

Bindungsspezifität: AA 51-150

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SERINC3 Antikörper ist konjugiert mit FITC

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Dog,Cow,Horse,Chicken,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human SERINC3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu SERINC3

Target: SERINC3 (Serine Incorporator 3 (SERINC3))

Andere Bezeichnung: SERINC3 (SERINC3 Produkte)

Synonyme: AIGP1 antikoerper, DIFF33 antikoerper, SBBI99 antikoerper, TDE antikoerper, TDE1 antikoerper, TMS-1 antikoerper, AA959945 antikoerper, AA960047 antikoerper, Tde1 antikoerper, serine incorporator 3 antikoerper, SERINC3 antikoerper, Serinc3 antikoerper

Hintergrund:

Synonyms: TMS 1, TMS-1, AIGP1, DF33, SBBI99, serine incorporator 3, TDE, TDE1, Tumor dferentially expressed protein 1, SERC3_HUMAN.

Background: TDE1, tumor differentially expressed protein 1, is a multi-pass membrane protein also known as serine incorporator 3. Also found on the membranes of the Golgi apparatus within cells, TDE1 is highly expressed in neuronal populations but is also found in thymus, kidney, liver and testis. Expression levels of TDE1 in tumors can be as much as tenfold the amount found in normal tissue of the same type. This increased expression implicates TDE1 as being involved in the cellular transformation from normal to malignant tissue. It is believed TDE1 contributes to oncogenesis by partially protecting cells from serum starvation and etoposide-induced apoptosis. The mechanism through which TDE1 protects cells is poorly understood, but may involve aberrant methylation of TDE1 complexes.

Gen-ID: 10955